The complement system in neurodegenerative diseasesJacqui Nimmo, B. Paul Morgan, Sarah M. Carpanini et al.|Clinical Science|2024Cited by 48
The schizophrenia-associated gene CSMD1 encodes a complement classical pathway inhibitor predominantly expressed by astrocytes and at synapses in mice and humansRobert A.J. Byrne, B. Paul Morgan, Jacqui Nimmo et al.|Brain Behavior and Immunity|2025Cited by 11
C3 and C3a as indicators of complement dysregulation in tauopathies and FTLD-associated disordersLaura Nicholls, Wioleta M. Zelek, Jacqui Nimmo et al.|Immunobiology|2025Cited by 2